Roche

Founded in 1896 and headquartered in Basel, Switzerland, Roche is a global leader in biotechnology and in-vitro diagnostics [1, 7]. The company operates through two primary divisions: Pharmaceuticals and Diagnostics [1, 4, 5]. It develops scientifically researched medicines and diagnostic solutions, leveraging a strategy that combines internal research capabilities with strategic partnerships and acquisitions, such as Genentech and Chugai [1, 2, 7]. Roche increasingly integrates advanced technology, including large-scale AI infrastructure and high-performance computing, to accelerate the development of therapeutics, clinical trials, and data-driven insights across its value chain [4, 7].

Roche's innovations address significant healthcare challenges in areas such as oncology, immunology, neuroscience, infectious diseases, and rare diseases [2, 5]. By providing clinicians and healthcare systems with precise diagnostic tools and effective, differentiated therapies, the company aims to improve patient outcomes and support the shift toward more efficient, preventive, and personalised healthcare [1, 2, 4, 7]. Roche serves a global patient population, playing a vital role in advancing standards of care for serious and life-threatening conditions while striving for long-term sustainability in healthcare delivery [2, 4, 7].